Cargando…
Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease
Neuronal ceroid lipofuscinosis 6 (CLN6) is a rare and fatal autosomal recessive disease primarily affecting the nervous system in children. It is caused by a pathogenic mutation in the CLN6 gene for which no therapy is available. Employing an untargeted metabolomics approach, we analyzed the metabol...
Autores principales: | Rus, Corina-Marcela, Polla, Daniel L., Di Bucchianico, Sebastiano, Fischer, Steffen, Hartkamp, Jörg, Hartmann, Guido, Alpagu, Yunus, Cozma, Claudia, Zimmermann, Ralf, Bauer, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613621/ https://www.ncbi.nlm.nih.gov/pubmed/37899458 http://dx.doi.org/10.1038/s41598-023-45789-7 |
Ejemplares similares
-
Dried Blood Spot (DBS) Methodology Study for Biomarker Discovery in Lysosomal Storage Disease (LSD)
por: Rus, Corina-Marcela, et al.
Publicado: (2021) -
Clinical and genetic characterization of a cohort of 97 CLN6 patients tested at a single center
por: Rus, Corina-Marcela, et al.
Publicado: (2022) -
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
por: Soldati, Chiara, et al.
Publicado: (2021) -
Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin
por: Minye, Helena M., et al.
Publicado: (2016) -
A comparative study of the degradation of yeast cyclins Cln1 and Cln2
por: Quilis, Inma, et al.
Publicado: (2016)